Asthma therapies get personal A new crop of biologic drugs promises to usher asthma treatment into the realm of personalised medicine.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
Inappropriate prescribing putting asthma patients’ lives at risk, warns charity Thousands of patients with asthma in the UK are not being prescribed the right medication to keep their condition under control, finds an audit of GP practice records by the charity body Asthma UK.…
Asthma treatment failure linked to older age but not gender Asthma patients aged 30 years and over are nearly twice as likely to experience treatment failure compared with younger sufferers.…
Pharmacies could play a role in reducing asthma-related deaths Pharmacies in areas with high rates of hospital visits for asthma dispensed fewer preventive medicines compared with reliever drugs, US research has found.…
Inhaled corticosteroids: managing side effects Inhaled corticosteroids are commonly prescribed but need careful management to minimise the risk of side effects.…
Mistakes made by patients using medical devices points to need for better trainingA research team sought to identify the factors associated with incorrect use of metered-dose inhalers and epinephrine autoinjectors.…
Asthma: long-term management Asthma management is based on a stepwise approach that should see medicines added or stopped based on patient symptoms.…
Asthma: pathophysiology, causes and diagnosis Despite asthma affecting more than 5.4 million people in the UK, there is no gold standard test and diagnosis is based on signs and symptoms.…
Combination inhaler Anoro Ellipta launched for COPD Anoro Ellipta, a novel inhaler containing a long-acting muscarinic receptor antagonist and a selective long-acting beta-2 adrenergic receptor agonist, may find a limited place in therapy.…
